76 related articles for article (PubMed ID: 22570452)
1. Perfluorinated compounds and immunotoxicity in children.
Zobel LR; Olsen GW; Butenhoff JL
JAMA; 2012 May; 307(18):1910; author reply 1910-1. PubMed ID: 22570452
[No Abstract] [Full Text] [Related]
2. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds.
Grandjean P; Andersen EW; Budtz-Jørgensen E; Nielsen F; Mølbak K; Weihe P; Heilmann C
JAMA; 2012 Jan; 307(4):391-7. PubMed ID: 22274686
[TBL] [Abstract][Full Text] [Related]
3. Perfluorinated compounds may lower vaccine protection in children.
Potera C
Environ Health Perspect; 2012 Apr; 120(4):A150-1. PubMed ID: 22469661
[No Abstract] [Full Text] [Related]
4. [Persistant perfluorinated compounds cause immunotoxic effects].
Heilmann C; Jensen L; Weihe P; Nielsen F; Knudsen LE; Budtz-Jørgensen E; Mølbak K; Grandjean P
Ugeskr Laeger; 2014 Feb; 176(9A):V09130572. PubMed ID: 25350410
[TBL] [Abstract][Full Text] [Related]
5. Estimated exposures to perfluorinated compounds in infancy predict attenuated vaccine antibody concentrations at age 5-years.
Grandjean P; Heilmann C; Weihe P; Nielsen F; Mogensen UB; Timmermann A; Budtz-Jørgensen E
J Immunotoxicol; 2017 Dec; 14(1):188-195. PubMed ID: 28805477
[TBL] [Abstract][Full Text] [Related]
6. Serum Vaccine Antibody Concentrations in Adolescents Exposed to Perfluorinated Compounds.
Grandjean P; Heilmann C; Weihe P; Nielsen F; Mogensen UB; Budtz-Jørgensen E
Environ Health Perspect; 2017 Jul; 125(7):077018. PubMed ID: 28749778
[TBL] [Abstract][Full Text] [Related]
7. [Immunological aspects of the infant's response to diphtheria and tetanus toxoids (author's transl)].
Levy FM; Cabau N; Fillastre C; Orssaud E
Ann Pediatr (Paris); 1979 Oct; 26(8):525-30. PubMed ID: 555626
[No Abstract] [Full Text] [Related]
8. Ranitidine improves postoperative suppression of antibody response to preoperative vaccination.
Nielsen HJ; Hammer JH; Moesgaard F; Heron I; Kehlet H
Surgery; 1992 Jan; 111(1):69-73. PubMed ID: 1728077
[TBL] [Abstract][Full Text] [Related]
9. [Characteristics of dynamics of antibody formation in children with chronic tonsillitis and adenoid hypertrophy immunized with the anti-pertussis-diphtheria-tetanus vaccine].
Giulling EV; Voloshchuk MI; Chernata LI; Belen'kaia LV
Zh Ushn Nos Gorl Bolezn; 1978; (6):50-3. PubMed ID: 735359
[No Abstract] [Full Text] [Related]
10. Antibody production following immunization with diphtheria and tetanus toxoids in children receiving chemotherapy during remission of malignant disease.
Kung FH; Orgel HA; Wallace WW; Hamburger RN
Pediatrics; 1984 Jul; 74(1):86-9. PubMed ID: 6588361
[TBL] [Abstract][Full Text] [Related]
11. Studies on the adequate composition of diphtheria and tetanus toxoids-with reference to the amounts of toxoids and aluminum adjuvant.
Someya S; Mizuhara H; Murata R; Kurokawa M
Jpn J Med Sci Biol; 1981 Feb; 34(1):21-35. PubMed ID: 7265558
[TBL] [Abstract][Full Text] [Related]
12. Specific titers to T-cell dependent and T-cell independent antigens.
Speirs RS
Prog Clin Biol Res; 1984; 161():99-115. PubMed ID: 6333036
[No Abstract] [Full Text] [Related]
13. [Vaccination against diphtheria and tetanus of children with thymus hyperplasia syndrome].
Ozeretskovskiĭ NA; Martynova MI; Shishatskaia SN; Kova'lskaia SIa; Veĭsfeĭler OIu; Vaganov PD; Mikheeva IG
Pediatriia; 1989; (9):26-31. PubMed ID: 2587163
[TBL] [Abstract][Full Text] [Related]
14. [Course of late toxicosis of pregnancy in relation to the degree of immunity to diphtheria and tetanus].
Seĭtzhanova KD
Akush Ginekol (Mosk); 1985 May; (5):32-3. PubMed ID: 3161388
[No Abstract] [Full Text] [Related]
15. Immunogenicity testing of diphtheria and tetanus vaccines by using isogenic mice with possible implications for potency testing.
Hendriksen CF; Slob W; vd Gun JW; Westendorp JH; den Bieman M; Hesp A; van Zutphen LF
Lab Anim; 1994 Apr; 28(2):121-9. PubMed ID: 8035562
[TBL] [Abstract][Full Text] [Related]
16. DPT immunisation and malnutrition.
Ghosh S; Mohan M; Khoche S; Ray SN; Ray K
Indian Pediatr; 1980 Feb; 17(2):123-5. PubMed ID: 7450843
[No Abstract] [Full Text] [Related]
17. [Immunity against diphtheria and tetanus in various age groups after 40 years since implementation of the mass vaccination program].
Fordymacka A
Przegl Epidemiol; 2000; 54(3-4):333-41. PubMed ID: 11349596
[TBL] [Abstract][Full Text] [Related]
18. Significance of the Lf content of diphtheria toxoid as a guide to its immunogenic value in DPT vaccine.
Habbu MK; Poonawalla CS; Parvatikar MS; Jadhav SS
Indian Pediatr; 1987 Feb; 24(2):141-4. PubMed ID: 3499394
[No Abstract] [Full Text] [Related]
19. Responses to rubella, tetanus, and diphtheria vaccines in otitis-prone and non-otitis-prone children.
Prellner K; Harsten G; Löfgren B; Christenson B; Heldrup J
Ann Otol Rhinol Laryngol; 1990 Aug; 99(8):628-32. PubMed ID: 2382936
[TBL] [Abstract][Full Text] [Related]
20. Potential protective immunogenicity of tetanus toxoid, diphtheria toxoid and Cross Reacting Material 197 (CRM197) when used as carrier proteins in glycoconjugates.
Bröker M
Hum Vaccin Immunother; 2016 Mar; 12(3):664-7. PubMed ID: 26327602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
